1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. ALIVUS LIFE SCIENCES LTD.
Alivus Life Sciences Ltd. Ask MarketMind AI v1.5
NSE: ALIVUS | BSE: 543322

Alivus Life Sciences Live Share Price Today, Share Analysis and Chart

Mid-range Performer
Iran war impact

Based on the analysis of the latest Annual Report (FY2024-25) and Quarterly Results for FY2025-26, the impact of the Iran-Israel war on Alivus Life Sciences Ltd. is categorized as Neutral. While the company remains cautious regarding geopolit...

Read More
925.45 -19.45 (-2.06%)
60,637
NSE+BSE Volume

NSE 16 Mar, 2026 3:31 PM (IST)

Watchlist

Portfolio

Alert
Loading... You have run out of DVM views!
Subscribe now to see details
Durability score
High Financial Strength
- / 100
Valuation Score
Mid Valuation
- / 100
Momentum Score
Technically Neutral
55.7 / 100
Mid-range Performer These stocks have strong quality. Their reasonable financials and technicals make them potentially attractive to investors View Similar Embed DVM
Analyst Price Target
1,158
1Yr Price target upside is 25%
3 analysts

16

S

7

W

4

O

3

T

SWOT Analysis

Alivus Life Sciences Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..
VOTE: Is Glenmark Life Sciences Ltd. worth buying?
133 Votes:
Buy 75.19%
Sell 12.03%
Hold 12.78%
BUY
SELL
HOLD
AI